Afuco™ Anti-Human IL27 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-IL27 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that bind IL-27 are used for treating the autoimmune disorders, such as asthma, chronic obstructive pulmonary disease (COPD), systemic lupus erythematosus (SLE), and inflammatory bowel disease.
Supplier Creative Biolabs
Product # AFC-406CL
Pricing Inquiry
Host Human
Target IL27
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Feedback